Lyn Daintree, CrystecPharma

In the last twenty years significant progress has been made in the application of supercritical fluid crystallisation of active molecules. This presentation provides an overview of the application of an anti-solvent supercritical fluid technology in designing product qualities such as polymorphic purity, particle size control etc. to meet the desired target product profile.

Emaillyn.daintree@crystecpharma.com

{loadposition itm201206p}